Manion Douglas J. 4
4 · Aclaris Therapeutics, Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Manion Douglas J.
Pres and COO
Transactions
- Purchase
Common Stock
2023-03-17$7.86/sh+6,300$49,532→ 12,800 total
Footnotes (1)
- [F1]The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $7.86 to $7.8641, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.